SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-20-008739
Filing Date
2020-04-29
Accepted
2020-04-28 19:51:22
Documents
3
Period of Report
2020-04-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vxrt20200428_8k.htm 8-K 30725
2 EXHIBIT 99.1 ex_183244.htm EX-99.1 16508
3 ex_183244img001.jpg GRAPHIC 4346
  Complete submission text file 0001437749-20-008739.txt   54819
Mailing Address 290 UTAH AVE., SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address 290 UTAH AVE., SUITE 200 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 20826879
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences